{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:13:07Z","timestamp":1793041987090,"version":"4.5.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent primary liver diseases worldwide and can develop into various conditions, ranging from simple steatosis, through non-alcoholic steatohepatitis (NASH), to fibrosis, and eventually cirrhosis and hepatocellular carcinoma. Nevertheless, there is no effective treatment for NAFLD due to the complicated etiology. Recently, activation of the NLPR3 inflammasome has been demonstrated to be a contributing factor in the development of NAFLD, particularly as a modulator of progression from initial hepatic steatosis to NASH. NLRP3 inflammasome, as a caspase-1 activation platform, is critical for processing key pro-inflammatory cytokines and pyroptosis. Various stimuli involved in NAFLD can activate the NLRP3 inflammasome, depending on the diverse cellular stresses that they cause. NLRP3 inflammasome-related inhibitors and agents for NAFLD treatment have been tested and demonstrated positive effects in experimental models. Meanwhile, some drugs have been applied in clinical studies, supporting this therapeutic approach. In this review, we discuss the activation, biological functions, and treatment targeting the NLRP3 inflammasome in the context of NAFLD progression. Specifically, we focus on the different types of therapeutic agents that can inhibit the NLRP3 inflammasome and summarize their pharmacological effectiveness for NAFLD treatment.<\/jats:p>","DOI":"10.3389\/fphar.2022.780496","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T09:53:10Z","timestamp":1646733190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":91,"title":["The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Lili","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.drudis.2012.05.012","article-title":"Farnesoid X Receptor Targeting to Treat Nonalcoholic Steatohepatitis","volume":"17","author":"Adorini","year":"2012","journal-title":"Drug Discov. Today"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3748\/wjg.v26.i16.1861","article-title":"Macrophages in Metabolic Associated Fatty Liver Disease","volume":"26","author":"Alharthi","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide Safety and Efficacy in Patients with Non-alcoholic Steatohepatitis (LEAN): a Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0234038","DOI":"10.1371\/journal.pone.0234038","article-title":"Pharmacological Inhibition of P2RX7 Ameliorates Liver Injury by Reducing Inflammation and Fibrosis","volume":"15","author":"Baeza-Raja","year":"2020","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08923973.2017.1327965","article-title":"Hepatoprotective Effect of Parthenolide in Rat Model of Nonalcoholic Fatty Liver Disease","volume":"39","author":"Bahabadi","year":"2017","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1002\/jcp.27513","article-title":"Repression of TXNIP-NLRP3 axis Restores Intestinal Barrier Function via Inhibition of Myeloperoxidase Activity and Oxidative Stress in Nonalcoholic Steatohepatitis","volume":"234","author":"Bai","year":"2019","journal-title":"J. Cel Physiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/liv.12570","article-title":"The Pan-Caspase Inhibitor Emricasan (IDN-6556) Decreases Liver Injury and Fibrosis in a Murine Model of Non-alcoholic Steatohepatitis","volume":"35","author":"Barreyro","year":"2015","journal-title":"Liver Int."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020291","article-title":"Naringenin Nano-Delivery Systems and Their Therapeutic Applications","volume":"13","author":"Bhia","year":"2021","journal-title":"Pharmaceutics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8962458","DOI":"10.1155\/2017\/8962458","article-title":"Deficiency of the Purinergic Receptor 2X7 Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 Inflammasome","volume":"2017","author":"Blasetti Fantauzzi","year":"2017","journal-title":"Oxid Med. Cel Longev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41598-017-03675-z","article-title":"Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-alcoholic Steatohepatitis","volume":"7","author":"Cabrera","year":"2017","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s10753-017-0628-z","article-title":"NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid","volume":"40","author":"Cai","year":"2017","journal-title":"Inflammation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"114941","DOI":"10.1016\/j.taap.2020.114941","article-title":"Benzyl Isothiocyanate Ameliorates High-Fat\/cholesterol\/cholic Acid Diet-Induced Nonalcoholic Steatohepatitis through Inhibiting Cholesterol crystal-activated NLRP3 Inflammasome in Kupffer Cells","volume":"393","author":"Chen","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2901871","DOI":"10.1155\/2018\/2901871","article-title":"NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ","volume":"2018","author":"Chen","year":"2018","journal-title":"Oxid Med. Cel Longev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/nu11122963","article-title":"Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-alcoholic Fatty Liver Disease through Regulation of mTORC1","volume":"11","author":"Choi","year":"2019","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/ijms21010360","article-title":"Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL\/6 Mice Model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 Pathway","volume":"21","author":"Chyau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 Directly Targets the NLRP3 ATP-Hydrolysis Motif for Inflammasome Inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2005.09.002","article-title":"Non-alcoholic Steatohepatitis: from Cell Biology to Clinical Practice","volume":"44","author":"Cortez-Pinto","year":"2006","journal-title":"J. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.3389\/fimmu.2019.02926","article-title":"Absence of the Caspases 1\/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice","volume":"10","author":"de Sant'Ana","year":"2019","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4183\/aeb.2020.223","article-title":"The Effects of Realsil (Silybin-Phospholipid-Vitamin E Complex) on Liver Enzymes in Patients with Non-alcoholic Fatty Liver Disease (Nafld) or Non-alcoholic Steato-Hepatitis (Nash): A Systematic Review and Meta-Analysis of Rcts","volume":"16","author":"Derakhshandeh-Rishehri","year":"2020","journal-title":"Acta Endocrinol. (Buchar)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"154299","DOI":"10.1016\/j.metabol.2020.154299","article-title":"Metabolic Liver Disease in Diabetes - from Mechanisms to Clinical Trials","author":"Dewidar","year":"2020","journal-title":"Metabolism"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 Receptor in Infection and Inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"28734","DOI":"10.1038\/srep28734","article-title":"New Insights into Salvianolic Acid A Action: Regulation of the TXNIP\/NLRP3 and TXNIP\/ChREBP Pathways Ameliorates HFD-Induced NAFLD in Rats","volume":"6","author":"Ding","year":"2016","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.phrs.2018.09.021","article-title":"Curcumin and Allopurinol Ameliorate Fructose-Induced Hepatic Inflammation in Rats via miR-200a-Mediated TXNIP\/NLRP3 Inflammasome Inhibition","volume":"137","author":"Ding","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"105666","DOI":"10.1016\/j.phrs.2021.105666","article-title":"Anticancer Activities of Dietary Benzyl Isothiocyanate: A Comprehensive Review","volume":"169","author":"Dinh","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/labinvest.2012.45","article-title":"Caspase-1-mediated Regulation of Fibrogenesis in Diet-Induced Steatohepatitis","volume":"92","author":"Dixon","year":"2012","journal-title":"Lab. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e56100","DOI":"10.1371\/journal.pone.0056100","article-title":"Caspase-1 as a central Regulator of High Fat Diet-Induced Non-alcoholic Steatohepatitis","volume":"8","author":"Dixon","year":"2013","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","article-title":"Increased Tim-3 Expression Alleviates Liver Injury by Regulating Macrophage Activation in MCD-Induced NASH Mice","volume":"16","author":"Du","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00210-019-01773-5","article-title":"NLRP3 Inhibitor Glibenclamide Attenuates High-Fat Diet and Streptozotocin-Induced Non-alcoholic Fatty Liver Disease in Rat: Studies on Oxidative Stress, Inflammation, DNA Damage and Insulin Signalling Pathway","volume":"393","author":"Dwivedi","year":"2020","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1590\/s0004-27302013000900005","article-title":"Exenatide Improves Type 2 Diabetes Concomitant with Non-alcoholic Fatty Liver Disease","volume":"57","author":"Fan","year":"2013","journal-title":"Arq Bras Endocrinol. Metabol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-inflammatory Fatty Liver Disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/jdi.12888","article-title":"Effects of Liraglutide, Metformin and Gliclazide on Body Composition in Patients with Both Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Randomized Trial","volume":"10","author":"Feng","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"B35","doi-asserted-by":"publisher","first-page":"28263","DOI":"10.1073\/pnas.2000466117","article-title":"Stimulation of Soluble Guanylate Cyclase Exerts Antiinflammatory Actions in the Liver through a VASP\/NF-\u03baB\/NLRP3 Inflammasome Circuit","volume":"117","author":"Flores-Costa","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jhep.2020.09.029","article-title":"Emricasan to Prevent New Decompensation in Patients with NASH-Related Decompensated Cirrhosis","volume":"74","author":"Frenette","year":"2021","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3390\/cells9102148","article-title":"The Absence of NLRP3-Inflammasome Modulates Hepatic Fibrosis Progression, Lipid Metabolism, and Inflammation in KO NLRP3 Mice during Aging","volume":"9","author":"Gallego","year":"2020","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ijbiomac.2021.05.066","article-title":"Lycium Barbarum Polysaccharide Combined with Aerobic Exercise Ameliorated Nonalcoholic Fatty Liver Disease through Restoring Gut Microbiota, Intestinal Barrier and Inhibiting Hepatic Inflammation","volume":"183","author":"Gao","year":"2021","journal-title":"Int. J. Biol. Macromol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jhep.2019.12.010","article-title":"Randomized Placebo-Controlled Trial of Emricasan for Non-alcoholic Steatohepatitis-Related Cirrhosis with Severe portal Hypertension","volume":"72","author":"Garcia-Tsao","year":"2020","journal-title":"J. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte Pyroptosis and Release of Inflammasome Particles Induce Stellate Cell Activation and Liver Fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e15141","DOI":"10.7759\/cureus.15141","article-title":"Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Non-alcoholic Steatohepatitis: A Clinical Review Article","volume":"13","author":"Ghazanfar","year":"2021","journal-title":"Cureus"},{"key":"B43","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.1073\/pnas.1821045116","article-title":"sGC Stimulator Praliciguat Suppresses Stellate Cell Fibrotic Transformation and Inhibits Fibrosis and Inflammation in Models of NASH","volume":"116","author":"Hall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.celrep.2018.07.068","article-title":"FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury","volume":"24","author":"Han","year":"2018","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/etm.2018.6300","article-title":"2,3,5,4'-tetrahydroxy-stilbene-2-O-\u03b2-D-glucoside Attenuates Methionine and Choline-Deficient Diet-Induced Non-alcoholic Fatty Liver Disease","volume":"16","author":"Han","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.024","article-title":"A Randomized, Placebo-Controlled Trial of Emricasan in Patients with NASH and F1-F3 Fibrosis","volume":"72","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated Dysbiosis Regulates Progression of NAFLD and Obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"21224","DOI":"10.1002\/jcp.28728","article-title":"Cannabidiol Protects Livers against Nonalcoholic Steatohepatitis Induced by High-Fat High Cholesterol Diet via Regulating NF-\u039ab and NLRP3 Inflammasome Pathway","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cel Physiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/antiox9111040","article-title":"Auranofin Attenuates Non-alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro","volume":"9","author":"Hwangbo","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1194\/jlr.M053785","article-title":"Cholesterol-lowering Drugs Cause Dissolution of Cholesterol Crystals and Disperse Kupffer Cell crown-like Structures during Resolution of NASH","volume":"56","author":"Ioannou","year":"2015","journal-title":"J. Lipid Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/nu12082435","article-title":"Effects of Resveratrol Supplementation in Patients with Non-alcoholic Fatty Liver Disease-A Meta-Analysis","volume":"12","author":"Jakubczyk","year":"2020","journal-title":"Nutrients"},{"key":"B52","doi-asserted-by":"publisher","first-page":"36209","DOI":"10.1038\/srep36209","article-title":"Lycium Barbarum Polysaccharide Attenuates High-Fat Diet-Induced Hepatic Steatosis by Up-Regulating SIRT1 Expression and Deacetylase Activity","volume":"6","author":"Jia","year":"2016","journal-title":"Sci. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a Selective and Direct NLRP3 Inhibitor to Treat Inflammatory Disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13950","article-title":"Functionality of Apigenin as a Potent Antioxidant with Emphasis on Bioavailability, Metabolism, Action Mechanism and In Vitro and In Vivo Studies: A Review","author":"Kashyap","year":"2021","journal-title":"J. Food Biochem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5114\/ceh.2019.83159","article-title":"Allopurinol Potentiates the Hepatoprotective Effect of Metformin and Vitamin E in Fructose-Induced Fatty Liver in Rats","volume":"5","author":"Khalaf","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/antiox9100924","article-title":"Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro","volume":"9","author":"Kuo","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide Inhibits the Cryopyrin\/Nalp3 Inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cel Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1879","DOI":"10.1038\/cddis.2015.248","article-title":"ER Stress Induces NLRP3 Inflammasome Activation and Hepatocyte Death","volume":"6","author":"Lebeaupin","year":"2015","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.fct.2016.07.035","article-title":"Hepatoprotection and Hepatotoxicity of Heshouwu, a Chinese Medicinal Herb: Context of the Paradoxical Effect","volume":"108","author":"Li","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/nu14010076","article-title":"Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis","volume":"14","author":"Li","year":"2021","journal-title":"Nutrients"},{"key":"B61","doi-asserted-by":"publisher","first-page":"806249","DOI":"10.3389\/fphar.2021.806249","article-title":"Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"560905","DOI":"10.3389\/fphar.2020.560905","article-title":"Activation of the AMPK-SIRT1 Pathway Contributes to Protective Effects of Salvianolic Acid A against Lipotoxicity in Hepatocytes and NAFLD in Mice","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.biopha.2018.11.101","article-title":"4-Acetylantroquinonol B from Antrodia Cinnamomea Enhances Immune Function of Dendritic Cells against Liver Cancer Stem Cells","volume":"109","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7499\/j.issn.1008-8830.2017.05.005","article-title":"[Clinical Efficacy of Compound Glycyrrhizin Tablets in the Treatment of Children with Nonalcoholic Fatty Liver Disease]","volume":"19","author":"Li","year":"2017","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B65","doi-asserted-by":"publisher","first-page":"9390786","DOI":"10.1155\/2018\/9390786","article-title":"Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway","volume":"2018","author":"Liang","year":"2018","journal-title":"Evid. Based Complement. Alternat Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"632767","DOI":"10.3389\/fphar.2021.632767","article-title":"Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.3748\/wjg.v23.i11.1964","article-title":"Traditional Chinese Herbal Extracts Inducing Autophagy as a Novel Approach in Therapy of Nonalcoholic Fatty Liver Disease","volume":"23","author":"Liu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"8158","DOI":"10.26355\/eurrev_201909_19036","article-title":"Cardiolipin Inhibitor Ameliorates the Non-alcoholic Steatohepatitis through Suppressing NLRP3 Inflammasome Activation","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e3292","DOI":"10.1002\/dmrr.3292","article-title":"Efficacy of Exenatide and Insulin Glargine on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes","volume":"36","author":"Liu","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020523","article-title":"A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in Andrographis Paniculata Reduces Steatohepatitis and Liver Injury in Mice Fed a High-Fat and High-Cholesterol Diet","volume":"12","author":"Liu","year":"2020","journal-title":"Nutrients"},{"key":"B71","doi-asserted-by":"publisher","first-page":"668418","DOI":"10.3389\/fphar.2021.668418","article-title":"Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-021-00348-7","article-title":"Berberine and its Derivatives Represent as the Promising Therapeutic Agents for Inflammatory Disorders","author":"Lu","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"02150","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct Contributions of Metabolic Dysfunction and Genetic Risk Factors in the Pathogenesis of Non-alcoholic Fatty Liver Disease","author":"Luukkonen","year":"2021","journal-title":"J. Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","article-title":"Apigenin Ameliorates HFD-Induced NAFLD through Regulation of the XO\/NLRP3 Pathways","volume":"71","author":"Lv","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fphar.2020.00185","article-title":"Berberine Inhibits Nod-like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS\/TXNIP Axis","volume":"11","author":"Mai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","article-title":"Inhibition of Receptor-Interacting Protein Kinase 1 Improves Experimental Non-alcoholic Fatty Liver Disease","volume":"72","author":"Majdi","year":"2020","journal-title":"J. Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","article-title":"Differential Activation of the Inflammasome by Caspase-1 Adaptors ASC and Ipaf","volume":"430","author":"Mariathasan","year":"2004","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the Gut-Liver axis in NASH Pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1152\/ajpendo.00058.2020","article-title":"\u03b2-Hydroxybutyrate Is Reduced in Humans with Obesity-Related NAFLD and Displays a Dose-dependent Effect on Skeletal Muscle Mitochondrial Respiration In Vitro","volume":"319","author":"Mey","year":"2020","journal-title":"Am. J. Physiology-Endocrinology Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"0","DOI":"10.3390\/cells8111356","article-title":"Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis","volume":"8","author":"Milito","year":"2019","journal-title":"Cells"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s10753-020-01190-4","article-title":"Mice Deficient in the IL-1\u03b2 Activation Genes Prtn3, Elane, and Casp1 Are Protected against the Development of Obesity-Induced NAFLD","volume":"43","author":"Mirea","year":"2020","journal-title":"Inflammation"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27368","article-title":"The Role of Inflammasome Complex in Ischemia-Reperfusion Injury","author":"Mohamadi","year":"2018","journal-title":"J. Cel Biochem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 Inflammasome Blockade Reduces Liver Inflammation and Fibrosis in Experimental NASH in Mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/md19060318","article-title":"Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis","volume":"19","author":"Oh","year":"2021","journal-title":"Mar. Drugs"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1007\/s10620-018-5268-0","article-title":"Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-\u039ab Pathway","volume":"63","author":"Ou","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","article-title":"Fatty Acid Activates NLRP3 Inflammasomes in Mouse Kupffer Cells through Mitochondrial DNA Release","volume":"332","author":"Pan","year":"2018","journal-title":"Cell Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.4161\/15548627.2014.984268","article-title":"Calcium Channel Blockers as Potential Therapeutics for Obesity-Associated Autophagy Defects and Fatty Liver Pathologies","volume":"10","author":"Park","year":"2014","journal-title":"Autophagy"},{"key":"B88","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1570161115666170621082237","article-title":"Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?","volume":"16","author":"Paschos","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13710","article-title":"A Narrative Review of Molecular Mechanism and Therapeutic Effect of Cannabidiol (CBD)","author":"Peng","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","article-title":"Mitochondrial Dysfunction-Related Lipid Changes Occur in Nonalcoholic Fatty Liver Disease Progression","volume":"59","author":"Peng","year":"2018","journal-title":"J. Lipid Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1038\/s41598-017-11744-6","article-title":"Lack of NLRP3-Inflammasome Leads to Gut-Liver axis Derangement, Gut Dysbiosis and a Worsened Phenotype in a Mouse Model of NAFLD","volume":"7","author":"Pierantonelli","year":"2017","journal-title":"Sci. Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"111988","DOI":"10.1016\/j.biopha.2021.111988","article-title":"Dieckol: a Brown Algal Phlorotannin with Biological Potential","volume":"142","author":"Rajan","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgh.14740","article-title":"Decrease in Fat De Novo Synthesis and Chemokine Ligand Expression in Non-alcoholic Fatty Liver Disease Caused by Inhibition of Mixed Lineage Kinase Domain-like Pseudokinase","volume":"34","author":"Saeed","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"02181","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A New Perspective on NAFLD: Focusing on Lipid Droplets","author":"Scorletti","year":"2021","journal-title":"J. Hepatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"774414","DOI":"10.3389\/fphar.2021.774414","article-title":"New Insights into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease","volume":"12","author":"Shao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1864307","DOI":"10.1155\/2018\/1864307","article-title":"Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL\/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway","volume":"2018","author":"Shao","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"B97","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/apt.15030","article-title":"Randomised Clinical Trial: Emricasan versus Placebo Significantly Decreases ALT and Caspase 3\/7 Activation in Subjects with Non-alcoholic Fatty Liver Disease","volume":"49","author":"Shiffman","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1007\/s11695-020-04571-8","article-title":"Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model","volume":"30","author":"Sun","year":"2020","journal-title":"Obes. Surg."},{"key":"B100","doi-asserted-by":"publisher","first-page":"109721","DOI":"10.1016\/j.biopha.2019.109721","article-title":"Silybin Ameliorates Hepatic Lipid Accumulation and Modulates Global Metabolism in an NAFLD Mouse Model","volume":"123","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","article-title":"Protective Effects of Glycyrrhizic Acid against Non-alcoholic Fatty Liver Disease in Mice","volume":"806","author":"Sun","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome Activation and Function in Liver Disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 Inflammasome Instigates Obesity-Induced Inflammation and Insulin Resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric Acid Regulates Hepatic Steatosis and Insulin Resistance through the NLRP3 Inflammasome-dependent Mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J. Hepatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3206587","DOI":"10.1155\/2019\/3206587","article-title":"Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease","volume":"2019","author":"Wang","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/nu13030856","article-title":"Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation","volume":"13","author":"Wang","year":"2021","journal-title":"Nutrients"},{"key":"B109","doi-asserted-by":"publisher","first-page":"111532","DOI":"10.1016\/j.biopha.2021.111532","article-title":"FTZ Attenuates Liver Steatosis and Fibrosis in the Minipigs with Type 2 Diabetes by Regulating the AMPK Signaling Pathway","volume":"138","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin Attenuates Non-alcoholic Fatty Liver Disease by Down-Regulating the NLRP3\/NF-\u039ab Pathway in Mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/bph.12226","article-title":"Quercetin and Allopurinol Reduce Liver Thioredoxin-Interacting Protein to Alleviate Inflammation and Lipid Accumulation in Diabetic Rats","volume":"169","author":"Wang","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2020.11.009","article-title":"NLRP3 Inflammasome Inhibitor CY-09 Reduces Hepatic Steatosis in Experimental NAFLD Mice","volume":"534","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B113","doi-asserted-by":"publisher","first-page":"11644","DOI":"10.1021\/acs.jafc.0c04791","article-title":"Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"3593951","DOI":"10.1155\/2016\/3593951","article-title":"The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis","volume":"2016","author":"Wei","year":"2016","journal-title":"Evid. Based Complement. Alternat Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"115655","DOI":"10.1016\/j.envpol.2020.115655","article-title":"Autophagy Mediates Perfluorooctanoic Acid-Induced Lipid Metabolism Disorder and NLRP3 Inflammasome Activation in Hepatocytes","volume":"267","author":"Weng","year":"2020","journal-title":"Environ. Pollut."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 Inflammasome Activation Is Required for Fibrosis Development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.14336\/AD.2019.0116","article-title":"Pyroptosis in Liver Disease: New Insights into Disease Mechanisms","volume":"10","author":"Wu","year":"2019","journal-title":"Aging Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/med.21717","article-title":"Therapeutic Potential of Phenylethanoid Glycosides: A Systematic Review","volume":"40","author":"Wu","year":"2020","journal-title":"Med. Res. Rev."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00786-2","article-title":"Sulforaphane Ameliorates Non-alcoholic Fatty Liver Disease in Mice by Promoting FGF21\/FGFR1 Signaling Pathway","author":"Wu","year":"2021","journal-title":"Acta Pharmacol. Sin"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijbiomac.2018.09.151","article-title":"Lycium Barbarum Polysaccharides Improve Hepatic Injury through NFkappa-B and NLRP3\/6 Pathways in a Methionine Choline Deficient Diet Steatohepatitis Mouse Model","volume":"120","author":"Xiao","year":"2018","journal-title":"Int. J. Biol. Macromol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","article-title":"Gasdermin D Plays a Key Role as a Pyroptosis Executor of Non-alcoholic Steatohepatitis in Humans and Mice","volume":"68","author":"Xu","year":"2018","journal-title":"J. Hepatol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine Oxidase in Non-alcoholic Fatty Liver Disease and Hyperuricemia: One Stone Hits Two Birds","volume":"62","author":"Xu","year":"2015","journal-title":"J. Hepatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1124\/dmd.118.082008","article-title":"Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation","volume":"46","author":"Yan","year":"2018","journal-title":"Drug Metab. Dispos"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/ijms21082790","article-title":"Sweroside Prevents Non-alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"24399","DOI":"10.1038\/srep24399","article-title":"A Pharmacological Inhibitor of NLRP3 Inflammasome Prevents Non-alcoholic Fatty Liver Disease in a Mouse Model Induced by High Fat Diet","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1007\/s43440-021-00227-1","article-title":"Pharmacological Properties of Baicalin on Liver Diseases: a Narrative Review","volume":"73","author":"Yang","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"112556","DOI":"10.1016\/j.jep.2020.112556","article-title":"Sweroside Ameliorates NAFLD in High-Fat Diet Induced Obese Mice through the Regulation of Lipid Metabolism and Inflammatory Response","volume":"255","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.metabol.2014.02.003","article-title":"Resveratrol Ameliorates Hepatic Metaflammation and Inhibits NLRP3 Inflammasome Activation","volume":"63","author":"Yang","year":"2014","journal-title":"Metabolism"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1142\/s0192415x20500937","article-title":"Antrodia Cinnamomea Attenuates Non-alcoholic Steatohepatitis by Suppressing NLRP3 Inflammasome Activation In Vitro and In Vivo","volume":"48","author":"Yen","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"111504","DOI":"10.1016\/j.biopha.2021.111504","article-title":"4-Acetylantroquinonol B Ameliorates Nonalcoholic Steatohepatitis by Suppression of ER Stress and NLRP3 Inflammasome Activation","volume":"138","author":"Yen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B131","doi-asserted-by":"publisher","first-page":"6659445","DOI":"10.1155\/2021\/6659445","article-title":"Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis","volume":"2021","author":"Ying","year":"2021","journal-title":"Evid. Based Complement. Alternat Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The Ketone Metabolite \u03b2-hydroxybutyrate Blocks NLRP3 Inflammasome-Mediated Inflammatory Disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"5271295","DOI":"10.1155\/2019\/5271295","article-title":"Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases","volume":"2019","author":"Yu","year":"2019","journal-title":"Mediators Inflamm."},{"key":"B134","doi-asserted-by":"publisher","first-page":"172715","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide Ameliorates Non-alcoholic Steatohepatitis by Inhibiting NLRP3 Inflammasome and Pyroptosis Activation via Mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1172\/JCI121842","article-title":"STING-mediated Inflammation in Kupffer Cells Contributes to Progression of Nonalcoholic Steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1096\/fj.201700602R","article-title":"Silybin Inhibits NLRP3 Inflammasome Assembly through the NAD+\/SIRT2 Pathway in Mice with Nonalcoholic Fatty Liver Disease","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"key":"B138","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cbi.2017.10.010","article-title":"Baicalin Protects AML-12 Cells from Lipotoxicity via the Suppression of ER Stress and TXNIP\/NLRP3 Inflammasome Activation","volume":"278","author":"Zhang","year":"2017","journal-title":"Chem. Biol. Interact"},{"key":"B139","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","article-title":"Impaired Mitophagy Triggers NLRP3 Inflammasome Activation during the Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis","volume":"99","author":"Zhang","year":"2019","journal-title":"Lab. Invest."},{"key":"B140","doi-asserted-by":"publisher","first-page":"108894","DOI":"10.1016\/j.abb.2021.108894","article-title":"Vitamin D Ameliorates High-Fat-Diet-Induced Hepatic Injury via Inhibiting Pyroptosis and Alters Gut Microbiota in Rats","volume":"705","author":"Zhang","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"B141","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1089\/ars.2014.5868","article-title":"Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation through NLRP3 Inflammasome Activation","volume":"22","author":"Zhang","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"B142","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New Mitochondrial DNA Synthesis Enables NLRP3 Inflammasome Activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1111\/bph.13513","article-title":"Hepatic NAD(+) Deficiency as a Therapeutic Target for Non-alcoholic Fatty Liver Disease in Ageing","volume":"173","author":"Zhou","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fendo.2018.00640","article-title":"Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein\/NLRP3 Pathways","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbrc.2018.09.134","article-title":"Liraglutide Protects Non-alcoholic Fatty Liver Disease via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model Induced by High-Fat Diet","volume":"505","author":"Zhu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B146","doi-asserted-by":"publisher","first-page":"791097","DOI":"10.3389\/fphar.2021.791097","article-title":"Proteomics Study Reveals the Anti-depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"12177","DOI":"10.18632\/aging.102559","article-title":"Effects of XIAP on High Fat Diet-Induced Hepatic Steatosis: a Mechanism Involving NLRP3 Inflammasome and Oxidative Stress","volume":"11","author":"Zilu","year":"2019","journal-title":"Aging (Albany NY)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.780496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T09:53:16Z","timestamp":1646733196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.780496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":147,"alternative-id":["10.3389\/fphar.2022.780496"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.780496","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"article-number":"780496"}}